$1.08
-0.05-4.42%
At close: -
$1.13
0.054.63%
After Hours: 4:24 PM EDT
Comments
Loading...
Eterna Therapeutics (NASDAQ:ERNA) Stock, Earnings Estimates, EPS, And Revenue
Eterna Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 13
EPS
$-1.020
Quarterly Revenue
$47K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$162K
Analyze the earnings history of Eterna Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Eterna Therapeutics (ERNA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Eterna Therapeutics (ERNA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Eterna Therapeutics (NASDAQ:ERNA) reporting earnings?
Eterna Therapeutics (ERNA) is scheduled to report earnings on November 26, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Eterna Therapeutics (NASDAQ:ERNA)?
The Actual EPS was $-1.02, which missed the estimate of $0.00.
What were Eterna Therapeutics’s (NASDAQ:ERNA) revenues?
The Actual Revenue was $47K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.